etrolizumab - CISMeF

Preferred Label : etrolizumab;

MeSH note : selectively blocks lymphocyte homing to the gastrointestinal tract without affecting lymphocyte trafficking to non-mucosal tissues;

CISMeF synonym : rhuMAb Beta7;

MeSH hyponym : PRO-145223; ANTI-BETA7; ANTI-.BETA.7; RHUMAB .BETA.7;

Is substance : O;

UNII : I2A72G2V3J;

Details

Origin ID

C559198;

UMLS CUI

C3177463;

Currated CISMeF NLP mapping
- Etrolizumab [NCIt concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
- antibodies, monoclonal, humanized [MeSH Descriptor]
Pharmacological action(s)
- gastrointestinal agents [MeSH Descriptor]
- immunologic factors [MeSH Descriptor]
Record concept(s)
- PRO145223 [MeSH concept]
- etrolizumab [MeSH concept]
- rhuMAb Beta7 [MeSH concept]
See also (suggested by CISMeF)
- integrin alpha4beta7 [MeSH Supplementary Concept]
- integrin alphaEbeta7 [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Etrolizumab [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients